KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Issued
Ratios

AbbVie (ABBV) Leases (2019 - 2025)

AbbVie (ABBV) has disclosed Leases for 7 consecutive years, with $737.0 million as the latest value for Q4 2025.

  • Quarterly Leases rose 2133.33% to $737.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $737.0 million through Dec 2025, up 2133.33% year-over-year, with the annual reading at $737.0 million for FY2025, 2133.33% up from the prior year.
  • Leases for Q4 2025 was $737.0 million at AbbVie, up from $33.0 million in the prior quarter.
  • The five-year high for Leases was $762.0 million in Q4 2021, with the low at $25.0 million in Q4 2022.
  • Average Leases over 5 years is $460.2 million, with a median of $737.0 million recorded in 2025.
  • The sharpest move saw Leases crashed 96.72% in 2022, then soared 2876.0% in 2023.
  • Over 5 years, Leases stood at $762.0 million in 2021, then plummeted by 96.72% to $25.0 million in 2022, then skyrocketed by 2876.0% to $744.0 million in 2023, then tumbled by 95.56% to $33.0 million in 2024, then skyrocketed by 2133.33% to $737.0 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $737.0 million, $33.0 million, and $744.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.